Correlation Between Suzhou Novoprotein and Linktel Technologies

Can any of the company-specific risk be diversified away by investing in both Suzhou Novoprotein and Linktel Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Suzhou Novoprotein and Linktel Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Suzhou Novoprotein Scientific and Linktel Technologies Co, you can compare the effects of market volatilities on Suzhou Novoprotein and Linktel Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Suzhou Novoprotein with a short position of Linktel Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Suzhou Novoprotein and Linktel Technologies.

Diversification Opportunities for Suzhou Novoprotein and Linktel Technologies

0.78

Correlation Coefficient

Suzhou Novoprotein  Linktel Technologies

Poor diversification

The 3 months correlation between Suzhou and Linktel is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Suzhou Novoprotein Scientific and Linktel Technologies Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Linktel Technologies and Suzhou Novoprotein is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Suzhou Novoprotein Scientific are associated (or correlated) with Linktel Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Linktel Technologies has no effect on the direction of Suzhou Novoprotein i.e., Suzhou Novoprotein and Linktel Technologies go up and down completely randomly.

Pair Corralation between Suzhou Novoprotein and Linktel Technologies

Assuming the 90 days trading horizon Suzhou Novoprotein Scientific is expected to under-perform the Linktel Technologies. But the stock apears to be less risky and, when comparing its historical volatility, Suzhou Novoprotein Scientific is 1.83 times less risky than Linktel Technologies. The stock trades about -0.05 of its potential returns per unit of risk. The Linktel Technologies Co is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  7,578  in Linktel Technologies Co on September 28, 2024 and sell it today you would earn a total of  432.00  from holding Linktel Technologies Co or generate 5.7% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.33%
Values	Daily Returns

Suzhou Novoprotein Scientific  vs.  Linktel Technologies Co

Suzhou Novoprotein

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Suzhou Novoprotein Scientific has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Linktel Technologies

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Linktel Technologies Co are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Linktel Technologies sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Suzhou Novoprotein and Linktel Technologies

The main advantage of trading using opposite Suzhou Novoprotein and Linktel Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Suzhou Novoprotein position performs unexpectedly, Linktel Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Linktel Technologies will offset losses from the drop in Linktel Technologies' long position.

The idea behind Suzhou Novoprotein Scientific and Linktel Technologies Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.